Mylan Launches Generic Zyprexa Zydis
Zyprexa Zydis is a thienobenzodiazepine indicated for the treatment of schizophrenia or the acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. The exact mechanism of action in schizophrenia and bipolar I disorder is unknown but it has been proposed that its efficacy in schizophrenia is mediated through a combination of dopamine and serotonin type 2 (5HT2) antagonism.
Olanzapine Orally Disintegrating Tables are available in 5mg, 10mg, 15mg, and 20mg strengths.
For more information call (800) 796-9526 or visit Mylan.com.